Robin Smith Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Exits
  • 1
Exits

Robin Smith General Information

Description

Ms. Robin Smith served as Chairman at MYnd Analytics. She received her M.D. from the Yale School of Medicine and an MBA from the Wharton School of Business. During her tenure as CEO of the NeoStem family of companies (NASDAQ: NBS now CLBS), which she led from 2006 to 2015, she pioneered the company's innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 26522 La Alameda
  • Mission Viejo, CA 92691
  • United States
+1 (888) 000-0000

Robin Smith Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000 000000000 07-Dec-2016 0000 000 Outcome Management (Healthcare) Generating Revenue 00000 00000
To view Robin Smith’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Robin Smith Exits (1)

Company Name Exit Date Exit Type Exit Size
0000 000000000 17-Jul-2019 000000000000000000
To view Robin Smith’s complete exits history, request access »

Robin Smith Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Robin Smith Team (1)

Name Title Deals Funds Boards Office
Robin Smith Angel Investor 0 Mission Viejo, CA
To view Robin Smith’s complete team members history, request access »